Skip to main content

Table 3 ORR of FOLFIRINOX and nabPGem in 1st and 2nd line

From: Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Efficacy parameter

FOLFIRINOX (n = 55)

nabPGem (n = 76)

1st-line

2nd-line

1st-line

2nd-line

(n = 42)

(n = 13)

(n = 41)

(n = 35)

Response rate

n (%)

n (%)

n (%)

n (%)

 PR

18 (43)

3 (23)

8 (20)

3 (9)

 SD

19 (45)

7 (54)

22 (54)

19 (54)

 PD

5 (12)

3 (23)

11 (27)

13 (37)